Analytical Data
-
Gene name
C1orf83
- Application
-
Alternative Names
TCEANC2; C1orf83; Transcription elongation factor A N-terminal and central domain-containing Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96MN5
-
Expression Region
1-208aa
-
AA Sequence
MDKFVIRTPRIQNSPQKKDSGGKVYKQATIESLKRVVVVEDIKRWKTMLELPDQTKENLVEALQELKKKIPSREVLKSTRIGHTVNKMRKHSDSEVASLAREVYTEWKTFTEKHSNRPSIEVRSDPKTESLRKNAQKLLSEALELKMDHLLVENIERETFHLCSRLINGPYRRTVRALVFTLKHRAEIRAQVKSGSLPVGTFVQTHKK
-
Molecular Weight
40.1kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf83, also known as chromosome 1 open reading frame 83, is a gene located on chromosome 1 that has garnered attention for its potential roles in cellular processes and disease mechanisms. Although its precise biological functions remain largely uncharacterized, emerging research indicates that C1orf83 may be implicated in various physiological pathways and could serve as a promising biomarker for certain diseases, particularly in the context of cancer and neurodegenerative disorders. The study of C1orf83 recombinant protein aims to elucidate its structure-function relationships and identify potential interactions with other proteins or cellular components. By producing and purifying the recombinant C1orf83 protein, researchers can investigate its biochemical properties and biological activities in vitro, facilitating a deeper understanding of its role in cellular signaling pathways. Furthermore, these studies may provide insights into the pathophysiological implications of C1orf83 dysregulation, contributing to the development of novel therapeutic strategies. Given the increasing interest in the functional characterization of unannotated proteins, the investigation of C1orf83 represents a significant step forward in unveiling the complexities of gene function and regulation in human health and disease.
